Cargando…

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”

Detalles Bibliográficos
Autores principales: Ramai, Daryl, Deliwala, Smit S., Chandan, Saurabh, Lester, Janice, Singh, Jameel, Samanta, Jayanta, di Nunzio, Sara, Perversi, Fabio, Cappellini, Francesca, Shah, Aashni, Ghidini, Michele, Sacco, Rodolfo, Facciorusso, Antonio, Giacomelli, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954193/
https://www.ncbi.nlm.nih.gov/pubmed/36831530
http://dx.doi.org/10.3390/cancers15041187
_version_ 1784894063969828864
author Ramai, Daryl
Deliwala, Smit S.
Chandan, Saurabh
Lester, Janice
Singh, Jameel
Samanta, Jayanta
di Nunzio, Sara
Perversi, Fabio
Cappellini, Francesca
Shah, Aashni
Ghidini, Michele
Sacco, Rodolfo
Facciorusso, Antonio
Giacomelli, Luca
author_facet Ramai, Daryl
Deliwala, Smit S.
Chandan, Saurabh
Lester, Janice
Singh, Jameel
Samanta, Jayanta
di Nunzio, Sara
Perversi, Fabio
Cappellini, Francesca
Shah, Aashni
Ghidini, Michele
Sacco, Rodolfo
Facciorusso, Antonio
Giacomelli, Luca
author_sort Ramai, Daryl
collection PubMed
description
format Online
Article
Text
id pubmed-9954193
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99541932023-02-25 Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947” Ramai, Daryl Deliwala, Smit S. Chandan, Saurabh Lester, Janice Singh, Jameel Samanta, Jayanta di Nunzio, Sara Perversi, Fabio Cappellini, Francesca Shah, Aashni Ghidini, Michele Sacco, Rodolfo Facciorusso, Antonio Giacomelli, Luca Cancers (Basel) Reply MDPI 2023-02-13 /pmc/articles/PMC9954193/ /pubmed/36831530 http://dx.doi.org/10.3390/cancers15041187 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Ramai, Daryl
Deliwala, Smit S.
Chandan, Saurabh
Lester, Janice
Singh, Jameel
Samanta, Jayanta
di Nunzio, Sara
Perversi, Fabio
Cappellini, Francesca
Shah, Aashni
Ghidini, Michele
Sacco, Rodolfo
Facciorusso, Antonio
Giacomelli, Luca
Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title_full Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title_fullStr Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title_full_unstemmed Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title_short Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
title_sort reply to lissing et al. comment on “ramai et al. risk of hepatocellular carcinoma in patients with porphyria: a systematic review. cancers 2022, 14, 2947”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954193/
https://www.ncbi.nlm.nih.gov/pubmed/36831530
http://dx.doi.org/10.3390/cancers15041187
work_keys_str_mv AT ramaidaryl replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT deliwalasmits replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT chandansaurabh replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT lesterjanice replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT singhjameel replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT samantajayanta replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT dinunziosara replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT perversifabio replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT cappellinifrancesca replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT shahaashni replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT ghidinimichele replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT saccorodolfo replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT facciorussoantonio replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT giacomelliluca replytolissingetalcommentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947